Lamarca A, Palmer DH, Wasan HS, Ross PJ, Ma YT, Arora A, et al. Second- line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial. Lancet Oncol (2021) 22(5):690 –701.